The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Omelchenko M.A.

Mental Health Research Centre

Migalina V.V.

Mental Health Research Centre

Kaleda V.G.

Mental Health Research Centre

Therapeutic targets of adolescent depression with attenuated symptoms of schizophrenia

Authors:

Omelchenko M.A., Migalina V.V., Kaleda V.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12): 69‑74

DOI: 10.17116/jnevro202412412169

Read: 1264 times

Download PDF (RU)
Contact the author
Table of contents

THERAPEUTIC TARGETS OF ADOLESCENT DEPRESSION WITH ATTENUATED SYMPTOMS OF SCHIZOPHRENIA
THERAPEUTIC TARGETS OF ADOLESCENT DEPRESSION WITH ATTENUATED SYMPTOMS OF SCHIZOPHRENIA

To cite this article:

Omelchenko MA, Migalina VV, Kaleda VG. Therapeutic targets of adolescent depression with attenuated symptoms of schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12):69‑74. (In Russ.)
https://doi.org/10.17116/jnevro202412412169

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Transcranial magnetic stimulation (rTMS) in the treatment of depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):55-59
Combined reha­bilitation therapy for postoperative urinary inco­ntinence in men. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(4):5-11
Transcranial magnetic stimulation in visual snow syndrome and functional diso­rders of visual perception. Russian Journal of Pain. 2025;(1):46-54
Abstract:

OBJECTIVE

Identification of therapeutic targets in the treatment of adolescent depression with attenuated symptoms of schizophrenia and assessment of the effectiveness of therapeutic interventions.

MATERIAL AND METHODS

One hundred and twenty-three patients (mean age 19.6±2.3 years) hospitalized in the clinic of the Mental Health Research Center for adolescent depression with non-psychotic mental disorders (ICD-10: F31, F32, F33, F34; F60; F21) were examined. Group 1 (44.7%, n=55) received only psychopharmacotherapy, Group 2 (24.4%, n=30) additionally received a course of repetitive transcranial magnetic stimulation (rTMS) therapy, Group 3 (13.0%, n=16) was administered to TMS, Group 4 (17.9%, n=22) received psychotherapy. Psychometric scales (HDRS SOPS CGI, SANS) were used. Statistical analysis was performed using Statistica 12 software.

RESULTS

The addition of additional non-drug treatment methods (brain feedback and TMS) did not lead to a reliable improvement in the results, and in some cases negative results were obtained. Psychotherapy conducted according to protocols, taking into account the clinical characteristics of patients, demonstrated a significantly higher treatment effectiveness (p<0.05).

CONCLUSION

Additional therapy targets for adolescent depression with attenuated symptoms of schizophrenia have been identified, including specific mild positive, negative symptoms, and disorganization symptoms, which, although not prominent, are fundamentally important in the effectiveness of treatment.

Keywords:

youth depression
attenuated symptoms of schizophrenia
psychopharmacotherapy
non-pharmacological treatment methods
rTMS
TMS
depression psychotherapy

Authors:

Omelchenko M.A.

Mental Health Research Centre

Migalina V.V.

Mental Health Research Centre

Kaleda V.G.

Mental Health Research Centre

Received:

21.06.2024

Accepted:

08.09.2024

Close metadata

References:

  1. Ihler HM, Lyngstad SH, Mørch-Johnsen LE, et al. A transdiagnostic approach to negative symptoms: exploring factor structure and negative symptoms in bipolar disorders. Frontiers in Psychiatry. 2023;14:1136097. https://doi.org/10.3389/fpsyt.2023.1136097
  2. Omelchenko MA. Clinical Features of Youth Depression with Attenuated Symptoms of the Schizophrenic Spectrum. Psikhiatriya. 2021;19(1):16-25. (In Russ.). https://doi.org/10.30629/2618-6667-2021-19-1-16-25
  3. Dong M, Zeng LN, Lu L, et al. Prevalence of suicide attempt in individuals with major depressive disorder: a meta-analysis of observational surveys. Psychological medicine. 2019;49(10):1691-1704. https://doi.org/10.1017/S0033291718002301
  4. Omelchenko MA, Zinkevich AS, Vares AY. Impulsivity and aggression in patients at risk for schizophrenia at the stage of remission after the first depressive episode. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(12):83-92. (In Russ.) https://doi.org/10.17116/jnevro202312312183
  5. Peng B, Liao J, Li Y, et al. Personality characteristics, defense styles, borderline symptoms, and non-suicidal self-injury in first-episode major depressive disorder. Frontiers in psychology. 2023;14:989711. https://doi.org/10.3389/fpsyg.2023.989711
  6. Rajewska-Rager A, Dmitrzak-Weglarz M, Lepczynska N, et al. Dimensions of the Hamilton Depression Rating Scale correlate with impulsivity and personality traits among youth patients with depression. Journal of clinical medicine. 2023;12(5):1744. https://doi.org/10.3390/jcm12051744
  7. Jinnin R, Furukawa TA, Kawakami N, et al. Subthreshold depression persists and increases the risk for depression in late adolescence: a one-year cohort study. International Journal of Neuropsychopharmacology. 2016;19(1):83.  https://doi.org/10.1093/ijnp/pyw043.228
  8. Dodd S, Bauer M, Carvalho AF, et al. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough? The World Journal of Biological Psychiatry. 2020;22(7):483-494.  https://doi.org/10.1080/15622975.2020.1851052
  9. Gong A, Gu F, Nan W, et al. A review of neurofeedback training for improving sport performance from the perspective of user experience. Frontiers in Neuroscience. 2021;15:638369. https://doi.org/10.3389/fnins.2021.638369
  10. Fernández-Alvarez J, Grassi M, Colombo D, et al. Efficacy of bio- and neurofeedback for depression: a meta-analysis. Psychological Medicine. 2022;52(2):201-216.  https://doi.org/10.1017/S0033291721004396
  11. Furukawa TA, Cipriani A, Cowen PJ, et al. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry. 2019;6(7):601-609.  https://doi.org/10.1016/S2215-0366(19)30217-2
  12. Danivas V, Venkatasubramanian G. Current perspectives on chlorpromazine equivalents: Comparing apples and oranges! Indian J Psychiatry. 2013;55(2):207-208.  https://doi.org/10.4103/0019-5545.111475
  13. Zimmerman M, Martinez JH, Young D, et al. Severity classification on the Hamilton Depression Rating Scale. J Affect Disord. 2013;150:384-388.  https://doi.org/10.1016/j.jad.2013.04.028
  14. Rucci P, Caporusso E, Sanmarchi F, et al. Italian Network for Research on Psychoses. The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia. BJPsych Open. 2023;9(5):e168. 2023;7;9(5):e168. https://doi.org/10.1192/bjo.2023.541
  15. Melnikov MY. The Current Evidence Level s for Biofeedback and Neurofeedback Interventions in Treating Depression: A Narrative Review. Neural Plast. 2021;2021:8878857. https://doi.org/10.1155/2021/8878857
  16. Rizvi S, Khan AM. Use of Transcranial Magnetic Stimulation for Depression. Cureus. 2019;11(5):e4736. https://doi.org/10.7759/cureus.4736
  17. Morrison AP, French P, Walford L, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk: Randomised controlled trial. British Journal of Psychiatry. 2004;185(4):291-297.  https://doi.org/10.1192/bjp.185.4.291
  18. van der Gaag M, Nieman M, Rietdijk DH, et al. Cognitive Behavioral Therapy for Subjects at Ultrahigh Risk for Developing Psychosis: A Randomized Controlled Clinical Trial, Schizophrenia Bulletin, 2012;38(6):1180-8.  https://doi.org/10.1093/schbul/sbs105
  19. Mei C, van der Gaag M, Nelson B, et al. Preventive interventions for individuals at ultra high risk for psychosis: an updated and extended meta-analysis. Clinical Psychology Review. 2021;86:102005. https://doi.org/10.1016/j.cpr.2021.102005
  20. Herrera SN, Sarac C, Phili A, et al. Psychoeducation for individuals at clinical high risk for psychosis: a scoping review. Schizophrenia research. 2023;252:148-158.  https://doi.org/10.1016/j.schres.2023.01.008
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.